DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Bayer AG (ADR) (NASDAQOTH: BAYRY)

139.34 -2.56 (-1.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BAYRY $139.34 -1.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $138.78
Previous Close $141.89
Daily Range $138.28 - $140.24
52-Week Range $124.36 - $150.63
Market Cap $115.2B
P/E Ratio 788.28
Dividend (Yield) $0.00 (1.5%)
Volume 49,804
Average Daily Volume 73,042
Current FY EPS $7.51

Sector

Healthcare

Industry

Pharmaceuticals

Bayer AG (ADR) (BAYRY) Description

The Company offers products, including ethical pharmaceuticals and other health care products, agricultural products and polymers. Website:

News & Commentary Rss Feed

3 Reasons to Buy the iShares MSCI EAFE ETF

The iShares MSCI EAFE Exchange Traded Fund offers instant international diversification among top companies in top countries for a reasonably low overhead cost.

3 Biotech Stocks to Buy in December

Three Motley Fool analysts tell investors which biotechnology stocks are on their wish list this month.

This Could Be the Next Big Pharma Buyout

Three Motley Fool analysts tell investors which three companies they think would be ripe for an acquisition.

Why Novartis and Regeneron Care About This Tiny Biotech Stock

Ophthotech's Fovista may tip the scale in favor of either Novartis' Lucentis or Regeneron's Eylea.

People Really Hate Monsanto, Its Latest Move Shows It Couldn't Care Less

As if people didn’t hate Monsanto enough, they’re now going against the EPA and further harming this crucial insect.

3 Small-Cap Biotech Stocks to Buy if the Market Crashes

Falling markets may be creating an opportunity to pick up these three biotechnology companies at discount prices.

The Surprising Over-the-Counter Pain Reliever Consumers Are Least Loyal To

The over-the-counter drug market could grow to reach $70 billion in sales by 2015, but according to Brand Keys, this OTC pain reliever is lagging far behind its peers in terms of customer loyalty.

New Study Touts Benefits of Organic Goods, Questions Pesticides and GMOs

Though not earth-shattering, the largest study to date represents a continued move away from chemical use.

Regeneron's $4.7 Billion Opportunity

Regeneron recently got some good news. Check out the video below for more information.

Why Are These 3 Dow Jones Stocks Crushing the Market in 2014?

Intel, Caterpillar, and Merck were the Dow's best performers in the first half of 2014. Why did these three stocks race ahead, and where are they going next?

See More BAYRY News...

BAYRY's Top Competitors

BAYRY $139.34 (-1.80%)
Current stock: BAYRY
JNJ $105.55 (-1.18%)
Current stock: JNJ
NVS $94.61 (0.04%)
Current stock: NVS
RHHBY $34.47 (-6.59%)
Current stock: RHHBY